Serrano-Fernandez Pablo, Dymerska Dagmara, Kurzawski Grzegorz, Derkacz Róża, Sobieszczańska Tatiana, Banaszkiewicz Zbigniew, Roomere Hanno, Oitmaa Eneli, Metspalu Andres, Janavičius Ramūnas, Elsakov Pavel, Razumas Mindaugas, Petrulis Kestutis, Irmejs Arvīds, Miklaševičs Edvīns, Scott Rodney J, Lubiński Jan
Hereditary Cancer Center, Department of genetics and Pathology, Pomeranian Medical University, Ulica Polabska 4, 70-115 Szczecin, Poland.
Department of Surgery, Collegium Medicum, Nicolaus Copernicus University, Ulica Jagiellonska 13-15, 85-067 Bydgoszcz, Poland.
Gastroenterol Res Pract. 2015;2015:204089. doi: 10.1155/2015/204089. Epub 2015 May 26.
The continued identification of new low-penetrance genetic variants for colorectal cancer (CRC) raises the question of their potential cumulative effect among compound carriers. We focused on 6 SNPs (rs380284, rs4464148, rs4779584, rs4939827, rs6983267, and rs10795668), already described as risk markers, and tested their possible independent and combined contribution to CRC predisposition. Material and Methods. DNA was collected and genotyped from 2330 unselected consecutive CRC cases and controls from Estonia (166 cases and controls), Latvia (81 cases and controls), Lithuania (123 cases and controls), and Poland (795 cases and controls). Results. Beyond individual effects, the analysis revealed statistically significant linear cumulative effects for these 6 markers for all samples except of the Latvian one (corrected P value = 0.018 for the Estonian, corrected P value = 0.0034 for the Lithuanian, and corrected P value = 0.0076 for the Polish sample). Conclusions. The significant linear cumulative effects demonstrated here support the idea of using sets of low-risk markers for delimiting new groups with high-risk of CRC in clinical practice that are not carriers of the usual CRC high-risk markers.
结直肠癌(CRC)新的低 penetrance 基因变异的持续发现引发了关于其在复合携带者中潜在累积效应的问题。我们聚焦于 6 个单核苷酸多态性(SNP,rs380284、rs4464148、rs4779584、rs4939827、rs6983267 和 rs10795668),这些已被描述为风险标志物,并测试了它们对 CRC 易感性可能的独立及联合作用。材料与方法。从爱沙尼亚(166 例病例和对照)、拉脱维亚(81 例病例和对照)、立陶宛(123 例病例和对照)以及波兰(795 例病例和对照)的 2330 例未经选择的连续 CRC 病例和对照中收集 DNA 并进行基因分型。结果。除个体效应外,分析显示除拉脱维亚样本外,这 6 个标志物对所有样本均有统计学显著的线性累积效应(爱沙尼亚样本校正 P 值 = 0.018,立陶宛样本校正 P 值 = 0.0034,波兰样本校正 P 值 = 0.0076)。结论。此处展示的显著线性累积效应支持在临床实践中使用低风险标志物组来界定新的 CRC 高风险组的观点,这些新组并非常见 CRC 高风险标志物的携带者。